Pancreatic Cancer Research

ResearcherTohoku UniversityActive in the last 2 years

Yasufumi Sato

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-6761-7553; OpenAlex author ID A5050198503. Sources: OpenAlex.

Their work

Papers
4 (first author 1, last author 1)
Trials
0
Grants
0
Labs led
1
Collaborators
11
Papers, trials and grants by year

2015: 2 papers · 2016: none · 2017: none · 2018: none · 2019: 1 paper · 2020: none · 2021: none · 2022: none · 2023: none · 2024: 1 paper

Papers 4

  1. Vasohibin-2-Targeting Therapies for the Treatment of Pancreatic Ductal Adenocarcinoma. First author DOI 10.1620/tjem.2023.j109↗
  2. Vasohibin-2 plays an essential role in metastasis of pancreatic ductal adenocarcinoma. Last author DOI 10.1111/cas.14041↗
  3. Expression of vasohibin-2 in pancreatic ductal adenocarcinoma promotes tumor progression and is associated with a poor clinical outcome. Co-author PMID 25916042↗
  4. [FOLFIRINOX Combination Chemotherapy in Patients with Metastatic or Recurrent Pancreatic Cancer--A Single Institution Experience]. Co-author PMID 26805364↗

Closest collaborators

The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yasuhiro Suzuki · 2 shared papers, 2019–2024 · strength 0.56
  2. Shin Hamada · 1 shared paper, 2019 · strength 0.11
  3. Rie Iida‐Norita · 1 shared paper, 2019 · strength 0.11
  4. Atsushi Masamune · 1 shared paper, 2019 · strength 0.11
  5. Toru Furukawa · 1 shared paper, 2019 · strength 0.11
  6. Jung Chul Kim · 1 shared paper, 2015 · strength 0.06
  7. Hyung-Seok Kim · 1 shared paper, 2015 · strength 0.06
  8. Yoshiaki Ohmura · 1 shared paper, 2015 · strength 0.04
  9. Shigeyuki Tamura · 1 shared paper, 2015 · strength 0.04
  10. Yutaka Takeda · 1 shared paper, 2015 · strength 0.04
  11. Yoshiteru Katsura · 1 shared paper, 2015 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.